CORDIS
EU research results

CORDIS

English EN
European human embryonic stem cell registry

European human embryonic stem cell registry

Objective

Human embryonic stem cell (hESC) research holds promise for the development of therapies for degenerative pathologies, offers a tool for drug discovery and toxicity tests, for studying human development, disease physiology and gene control. hESC lines are currently derived in an increasing number of laboratories in Europe and around the world. A detailed registry of available cell lines will promote the validation and efficient use of these precious cells for research and application.

Comparable information is needed about the origin of the cell lines, the methodology and standards for their derivation and the characteristics to assess their availability for research and future therapies. The growing use of hESC by the scientific community demands a high quality and comprehensive registry. The aim of the proposed European hESC registry is to promote access to all hESC lines derived in Europe and transparency about their characteristics.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN

Address

CharitÉPlatz 1
Berlin

Germany

Administrative Contact

Joeri BORSTLAP (Mr)

Participants (13)

Sort alphabetically

Expand all

CENTRE DE MEDICINA REGENERATIVA DE BARCELONA

Spain

NATIONAL BIOLOGICAL STANDARDS BOARD

United Kingdom

INSTITUTO DE SALUD CARLOS III

Spain

AGENCE DE LA BIOMEDECINE

France

VRIJE UNIVERSITEIT BRUSSEL

Belgium

HADASSAH MEDICAL ORGANIZATION

Israel

KAROLINSKA INSTITUTET

Sweden

HUBRECHT LABORATORY /KNAW

Netherlands

MASARYKOVA UNIVERZITA

Czechia

HELSINGIN YLIOPISTO

Finland

REGION HOVEDSTADEN

Denmark

ACADEMISCH ZIEKENHUIS LEIDEN,ACTING UNDER THE NAME OF LUMC

Netherlands

UNIVERSITÉ DE GENÈVE

Switzerland

Project information

Grant agreement ID: 37820

  • Start date

    1 March 2007

  • End date

    28 February 2010

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 1 048 050

  • EU contribution

    € 1 048 050

Coordinated by:

CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN

Germany